The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2025

Filed:

May. 20, 2019
Applicant:

Novo Nordisk A/s, Bagsvaerd, DK;

Inventors:

Alan John Michelich, Seattle, WA (US);

Thomas Dedenroth Miller, Seattle, WA (US);

Oleksandr Shvets, Everett, WA (US);

Anuar Imanbayev, Seattle, WA (US);

Brad Warren Van Orden, Seattle, WA (US);

Assignee:

Novo Nordisk A/S, Bagsvaerd, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/28 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61K 38/26 (2006.01); A61P 3/10 (2006.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01);
U.S. Cl.
CPC ...
A61K 38/28 (2013.01); A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); A61P 3/10 (2018.01); G16H 20/17 (2018.01); A61K 38/26 (2013.01); A61K 2300/00 (2013.01); G16H 10/60 (2018.01);
Abstract

The invention relates to a novel administration regime useful in the treatment of diseases or conditions where administration of insulin will be of benefit. In particular, the invention relates to a long-acting or ultra-long acting insulin for use in treating a disease or condition where administration of insulin will be of benefit, wherein the administration of said insulin includes or consists of one or more of the following steps: (a) obtaining a first data set of the subject, (b) obtaining a second data set of the subject, (c) obtaining a first data structure of the subject, and (d) obtaining a second data structure of the subject. When a determination is made that the at least first data structure, second data structure, first data set, and second data set collectively do contain the set of evaluation information, the device further includes providing the long-acting or ultra-long-acting insulin dose guidance recommendation.


Find Patent Forward Citations

Loading…